000 01595 a2200433 4500
005 20250516145858.0
264 0 _c20131119
008 201311s 0 0 eng d
022 _a1865-3774
024 7 _a10.1007/s12185-013-1333-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGandhi, S
245 0 0 _aAllogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.
_h[electronic resource]
260 _bInternational journal of hematology
_cMay 2013
300 _a573-80 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAge Factors
650 0 4 _aAlemtuzumab
650 0 4 _aAnemia, Aplastic
_xcomplications
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aAntigens, CD
650 0 4 _aAntigens, Neoplasm
650 0 4 _aCD52 Antigen
650 0 4 _aGlycoproteins
_xantagonists & inhibitors
650 0 4 _aGraft vs Host Disease
_xetiology
650 0 4 _aHematopoietic Stem Cell Transplantation
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aInfections
_xetiology
650 0 4 _aTransplantation Conditioning
650 0 4 _aTransplantation, Homologous
650 0 4 _aTreatment Outcome
700 1 _aKulasekararaj, A G
700 1 _aMufti, G J
700 1 _aMarsh, J C W
773 0 _tInternational journal of hematology
_gvol. 97
_gno. 5
_gp. 573-80
856 4 0 _uhttps://doi.org/10.1007/s12185-013-1333-9
_zAvailable from publisher's website
999 _c22713583
_d22713583